Southeast Asia Steals Indian Pharma
Red tape, idiosyncratic laws and frustrating regulatory architecture are propelling Indian clinical trials and pharmaceutical companies to relocate to more conducive business environments in Southeast Asia.
The beneficiaries, according to the Associated Chambers of Commerce and Industry of India, are Cambodia, the Philippines, Singapore, Thailand, Vietna…
Keep reading with a 7-day free trial
Subscribe to Asia Sentinel to keep reading this post and get 7 days of free access to the full post archives.